Navigation Links
MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Date:10/29/2010

potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the conduct and completion of clinical trials, and relating to the preparation and filing of a New Drug Application and the regulatory process to have the Company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, available at http://edgar.sec.gov. CONTACTS:Nicole FoderaroWCG(415) 946-1058nfoderaro@wcgworld.com
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)...  Cohen, Placitella & Roth, PC is investigating ... Nymox Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 31, 2011 through November 2, 2014 ("Class Period").  ... its officers and directors publically disseminated materially false ... and 20(a) of the Securities Exchange Act of ...
(Date:11/26/2014)... -- Over 100 million adults suffer from chronic pain and ... Chronic and acute pain dramatically impacts quality of life. ... the need for non-surgical, interventional solutions and medication management ... October 28th, a new pain management center opened its ... community.  This new facility boasts cutting edge technologies and ...
(Date:11/26/2014)... , Nov. 26, 2014 Zynerba ... the development of innovative transdermal synthetic cannabinoid treatments, today ... Jaffray 26th Annual Healthcare Conference 2014. The conference will ... York Palace in New York . ... present at 4:50 pm on Tuesday, December 2. ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... April 22 Genoptix, Inc. (Nasdaq: GXDX ), a specialized ... for the first quarter 2010 after closing of the NASDAQ Global Select Market ... , , ... , Ph.D., and other members of senior management will take place on the ...
... REDWOOD CITY, Calif. , April 22 Codexis, Inc. announced today ... stock, at $13.00 per share. All shares are being sold by ... an additional 900,000 shares at the initial public offering price to cover overallotments, ... the symbol "CDXS." , , , ...
Cached Medicine Technology:Genoptix, Inc. to Announce First Quarter 2010 Financial Results 2Genoptix, Inc. to Announce First Quarter 2010 Financial Results 3Codexis, Inc. Announces Pricing of Initial Public Offering 2
(Date:11/27/2014)... (PRWEB) November 27, 2014 Jeffrey ... years in the Charlotte area providing audits, reviews, ... services to businesses of varying size across numerous ... owners to meet all of their accounting and ... through the QuickBooks ProAdvisor Program. When asking Mr. ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VogueQueen.com is ... items for ladies across the world. As the premier ... accessories, VogueQueen.com is proud to release a huge selection ... high quality outfits, it is also providing many beautiful ... VogueQueen prom gowns at discounted prices. , “VogueQueen.com ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Dr. Ronald Receveur, ... has a few oral health tips before patients dig ... offers Louisville and New Albany affordable cosmetic dentistry, ... high in starch and sugar. While the staff wishes everyone ... helpful tips for how patients can enjoy a feast that ...
(Date:11/27/2014)... children to help with chores while they are home from ... boosts self-esteem, and above all, helps parents maintain a somewhat ... how do you encourage your children to want to help? ... Child Development Journal, there is. The study found that adults’ ... to lend a hand. , The study found that ...
(Date:11/27/2014)... Ethane Web Technologies, which is an ... reputation management service. , The company has designed ... world of internet marketing and algorithms of major search ... Web Technologies does not work with the same strategy ... to reach a conclusion what will work for the ...
Breaking Medicine News(10 mins):Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ethane Web Technologies Announces Online Reputation Management Service 2
... reports little coronary benefit, regardless of when treatment begins , ... not lower the odds of heart trouble in women who ... of menopause, a new study reports. , In fact, the ... attacks for the first two years of use. , ...
... ... Awards (FOYA) were announced by the program’s sponsors, ISPE, INTERPHEX, and Pharmaceutical Processing ... their operations to yield top quality products. Two of this year’s winning companies ... ...
... ... Green” to the Next Level., , ... Tampa, FL (PRWEB) February 18, 2010 -- Super Green Technologies, ... tankless water heaters on the market today. Super Green Technologies water heaters utilize ...
... Van Andel Research Institute (VARI) researchers have found a ... currently the first line of defense against clear cell renal ... Most patients who show a positive response to sunitinib develop ... Kidney cancer is among the 10 most common cancers ...
... due to complications arising from pregnancy and childbirth. Half of ... the King Juan Carlos University (URJC) in Madrid says these ... but rather from a lack of basic healthcare measures. ... situation and of the inequalities between men and women", Jos ...
... ... Global Business to Business (B2B) Video Network , ... Toronto, Canada (PRWEB) February 18, 2010 -- BCS Global ... telepresence solutions, today announced that it has launched the PSVN (Public Switched Video Network) ...
Cached Medicine News:Health News:Early On, Hormone Therapy May Raise Women's Heart Risks 2Health News:Early On, Hormone Therapy May Raise Women's Heart Risks 3Health News:Awards Strengthen Stonhard's Reputation for High-Performing Floors in the World's Most Prominent Pharmaceutical Facilities 2Health News:First Breakthrough in Water Heating Technology! 2Health News:First Breakthrough in Water Heating Technology! 3Health News:VARI findings may help patients with deadly kidney cancer 2Health News:Most maternal deaths in sub-Saharan Africa could be avoided 2Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 2Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 3Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 4Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 5
... flexible, total solution. , ,Kojair Tech Oy has ... A major part of our production is marketed ... the different areas of clean-air needs are a ... is a comprehensive supplier. We are able to ...
... 95% media meets today's ASHRAE ... contaminant reduction. The unique, patented ... DEFIANT filters creates a media ... respect to initial efficiency, average ...
The Universal Knee Positioner(s)™ reduces surgeon fatigue while assisting in the stabilization of a patient's leg during surgury....
BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
Medicine Products: